Skip to main content
NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
4.730
+0.110 (2.38%)
At close: Dec 20, 2024, 4:00 PM
4.896
+0.166 (3.50%)
After-hours: Dec 20, 2024, 7:18 PM EST

NEXGEL Revenue

NEXGEL had revenue of $2.94M in the quarter ending September 30, 2024, with 140.79% growth. This brings the company's revenue in the last twelve months to $6.73M, up 90.57% year-over-year. In the year 2023, NEXGEL had annual revenue of $4.09M with 99.66% growth.

Revenue (ttm)
$6.73M
Revenue Growth
+90.57%
P/S Ratio
4.31
Revenue / Employee
$354,158
Employees
19
Market Cap
35.56M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.09M2.04M99.66%
Dec 31, 20222.05M497.00K32.04%
Dec 31, 20211.55M877.00K130.12%
Dec 31, 2020674.00K-43.00K-6.00%
Dec 31, 2019717.00K-1.50M-67.60%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SAB Biotherapeutics 1.51M
OneMedNet 957.65K
VYNE Therapeutics 493.00K
Nexalin Technology 162.08K
Actinium Pharmaceuticals 81.00K
Revenue Rankings

NXGL News

More News